Hsu, C.-N.; Hou, C.-Y.; Chang-Chien, G.-P.; Lin, S.; Yang, H.-W.; Tain, Y.-L.
Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites. Biomedicines 2020, 8, 567.
https://doi.org/10.3390/biomedicines8120567
AMA Style
Hsu C-N, Hou C-Y, Chang-Chien G-P, Lin S, Yang H-W, Tain Y-L.
Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites. Biomedicines. 2020; 8(12):567.
https://doi.org/10.3390/biomedicines8120567
Chicago/Turabian Style
Hsu, Chien-Ning, Chih-Yao Hou, Guo-Ping Chang-Chien, Sufan Lin, Hung-Wei Yang, and You-Lin Tain.
2020. "Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites" Biomedicines 8, no. 12: 567.
https://doi.org/10.3390/biomedicines8120567
APA Style
Hsu, C.-N., Hou, C.-Y., Chang-Chien, G.-P., Lin, S., Yang, H.-W., & Tain, Y.-L.
(2020). Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites. Biomedicines, 8(12), 567.
https://doi.org/10.3390/biomedicines8120567